BTN3A2 Protein (AA 30-248) (His-Avi Tag,Biotin)
-
- Target Alle BTN3A2 Proteine anzeigen
- BTN3A2 (Butyrophilin, Subfamily 3, Member A2 (BTN3A2))
- Protein-Typ
- Recombinant
- Proteineigenschaft
- AA 30-248
-
Spezies
- Human
-
Quelle
- HEK-293 Cells
- Aufreinigungstag / Konjugat
- Dieses BTN3A2 Protein ist gelabelt mit His-Avi Tag,Biotin.
- Verwendungszweck
- Biotinylated Human BTN3A2 Protein
- Sequenz
- Gln30-Trp248
- Produktmerkmale
- Recombinant Biotinylated Human BTN3A2 Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Gln30-Trp248.
- Reinheit
- > 95 % as determined by Tris-Bis PAGE,> 93 % as determined by HPLC
- Sterilität
- 0.22 μm filtered
- Endotoxin-Niveau
- Less than 1EU per μg by the LAL method.
- Top Product
- Discover our top product BTN3A2 Protein
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in distilled water.
- Buffer
- Lyophilized from 0.22μm filtered solution in PBS ( pH 7.4). Normally 8 % trehalose is added as protectant before lyophilization.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- -20 to -80°C for 12 months as supplied from date of receipt.,-80°C for 3-6 months after reconstitution.,2-8°C for 2-7 days after reconstitution.,Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- BTN3A2 (Butyrophilin, Subfamily 3, Member A2 (BTN3A2))
- Andere Bezeichnung
- BTN3A2 (BTN3A2 Produkte)
- Synonyme
- BT3.2 Protein, BTF4 Protein, CD277 Protein, butyrophilin subfamily 3 member A2 Protein, butyrophilin-like protein 1 Protein, butyrophilin subfamily 1 member A1 Protein, BTN3A2 Protein, LOC481727 Protein, LOC615223 Protein, LOC100599692 Protein
- Hintergrund
- BTN3A2/BT3.2 butyrophilin mRNA expression by tumoral cells was previously identified as a prognostic factor in a small cohort of high grade serous epithelial ovarian cancer (HG-EOC).In conclusion, BT3.2 protein is a potential prognostic biomarker for the identification of HG-EOC patients with better outcome. In contrast, high CD206 /CD68 expression is associated with high risk of disease progression.
- Molekulargewicht
- 26.5 kDa. Due to glycosylation, the protein migrates to 30-38 kDa based on Tris-Bis PAGE result.
-